Page 1 of 47
NR 565 ADVANCED PHARMACOLOGY EXAM PREP 2026 QUESTIONS WITH
VERIFIED ANSWERS DETAILED RATIONALES GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics Foundations (Questions 1–
25)
1. A nurse practitioner is evaluating a drug's safety profile and notes that it has a
narrow therapeutic index. What clinical implication does this have for
prescribing?
A. The drug is safe for use in all patients
B. The drug requires routine serum level monitoring
C. The drug can be prescribed without dose adjustments
D. The drug has no significant adverse effects
Rationale: B. Drugs with a narrow therapeutic index have a small difference
between therapeutic and toxic doses, requiring careful monitoring of serum
drug levels.
2. A patient is taking a medication that is 90% protein-bound. What percentage
of the drug is pharmacologically active?
A. 90%
B. 50%
C. 10%
D. 100%
Rationale: C. Only the free (unbound) fraction of a drug is pharmacologically
active. If a drug is 90% protein-bound, 10% is free and active.
3. Which of the following best describes the term "potency" in pharmacology?
A. The maximum effect a drug can produce
B. The dose required to produce a given effect
1|Page
,Page 2 of 47
C. The rate at which a drug is absorbed
D. The duration of a drug's action
Rationale: B. Potency refers to the amount of drug needed to produce a given
effect. A more potent drug requires a lower dose to produce the same effect.
4. A drug with a high therapeutic index is generally considered:
A. Potentially toxic at standard doses
B. Relatively safe
C. Likely to cause significant side effects
D. Highly potent
Rationale: B. A high therapeutic index indicates a wide margin of safety between
the therapeutic and lethal doses.
5. Which of the following describes a drug that binds to a receptor and produces
a maximal biological response?
A. Full Agonist
B. Antagonist
C. Partial Agonist
D. Inverse Agonist
Rationale: A. A full agonist binds to a receptor and produces a maximal
biological response.
6. Pharmacokinetics is best defined as the study of:
A. The study of drug effects on the body
B. The study of drug movement throughout the body
C. The study of drug toxicity
D. The study of drug interactions
Rationale: B. Pharmacokinetics encompasses the four basic processes of
absorption, distribution, metabolism, and excretion (ADME).
7. A drug with a half-life of 6 hours will reach steady state in approximately:
A. 6 hours
B. 12 hours
C. 24–30 hours
2|Page
,Page 3 of 47
D. 48 hours
Rationale: C. Steady state is reached after approximately 4–5 half-lives.
8. What is the primary purpose of administering a loading dose of a medication?
A. To maintain steady-state levels
B. To rapidly achieve therapeutic drug concentrations
C. To reduce the risk of adverse effects
D. To prolong the drug's half-life
Rationale: B. A loading dose is given to rapidly achieve therapeutic plasma
concentrations.
9. A patient with hepatic impairment is prescribed a drug that undergoes
extensive first-pass metabolism. What is the most likely effect?
A. Decreased bioavailability
B. Increased bioavailability
C. No change in bioavailability
D. Variable bioavailability
Rationale: B. Hepatic impairment reduces first-pass metabolism, leading to
increased bioavailability.
10. What is the definition of a prodrug?
A. A drug that is active immediately upon administration
B. A drug that requires metabolic activation to become active
C. A drug that is excreted unchanged in the urine
D. A drug that has no therapeutic effect
Rationale: B. A prodrug is an inactive compound that requires metabolic
activation in the body.
11. Which of the following is a Phase II metabolic reaction?
A. Oxidation
B. Reduction
C. Hydrolysis
D. Glucuronidation
Rationale: D. Phase II reactions involve conjugation, such as glucuronidation.
3|Page
, Page 4 of 47
12. A drug follows zero-order kinetics. What does this mean?
A. A constant fraction of the drug is eliminated per unit time
B. A constant amount of drug is eliminated per unit time
C. The drug is eliminated more rapidly at higher concentrations
D. The drug is eliminated exponentially
Rationale: B. Zero-order kinetics means a constant amount of drug is eliminated
per unit time.
13. What is the primary factor that determines the onset of action of a drug?
A. Route of administration
B. Protein binding
C. Volume of distribution
D. Therapeutic index
Rationale: A. The route of administration significantly affects the onset of action.
14. A patient is taking a medication that is a potent enzyme inhibitor. What
effect will this have on other medications metabolized by the same enzyme?
A. Decreased serum levels of the other medications
B. Increased serum levels of the other medications
C. No effect on other medications
D. Decreased toxicity of other medications
Rationale: B. Enzyme inhibitors decrease the metabolism of other drugs, leading
to increased serum levels.
15. What is the definition of tachyphylaxis?
A. An increased response to a drug after repeated administration
B. A decreased response to a drug after repeated administration
C. An allergic reaction to a drug
D. An idiosyncratic reaction to a drug
Rationale: B. Tachyphylaxis is a rapid decrease in response to a drug after
repeated administration.
16. Which of the following is a primary factor that determines the distribution of
a drug?
A. Blood flow to tissues and protein binding
4|Page
NR 565 ADVANCED PHARMACOLOGY EXAM PREP 2026 QUESTIONS WITH
VERIFIED ANSWERS DETAILED RATIONALES GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics Foundations (Questions 1–
25)
1. A nurse practitioner is evaluating a drug's safety profile and notes that it has a
narrow therapeutic index. What clinical implication does this have for
prescribing?
A. The drug is safe for use in all patients
B. The drug requires routine serum level monitoring
C. The drug can be prescribed without dose adjustments
D. The drug has no significant adverse effects
Rationale: B. Drugs with a narrow therapeutic index have a small difference
between therapeutic and toxic doses, requiring careful monitoring of serum
drug levels.
2. A patient is taking a medication that is 90% protein-bound. What percentage
of the drug is pharmacologically active?
A. 90%
B. 50%
C. 10%
D. 100%
Rationale: C. Only the free (unbound) fraction of a drug is pharmacologically
active. If a drug is 90% protein-bound, 10% is free and active.
3. Which of the following best describes the term "potency" in pharmacology?
A. The maximum effect a drug can produce
B. The dose required to produce a given effect
1|Page
,Page 2 of 47
C. The rate at which a drug is absorbed
D. The duration of a drug's action
Rationale: B. Potency refers to the amount of drug needed to produce a given
effect. A more potent drug requires a lower dose to produce the same effect.
4. A drug with a high therapeutic index is generally considered:
A. Potentially toxic at standard doses
B. Relatively safe
C. Likely to cause significant side effects
D. Highly potent
Rationale: B. A high therapeutic index indicates a wide margin of safety between
the therapeutic and lethal doses.
5. Which of the following describes a drug that binds to a receptor and produces
a maximal biological response?
A. Full Agonist
B. Antagonist
C. Partial Agonist
D. Inverse Agonist
Rationale: A. A full agonist binds to a receptor and produces a maximal
biological response.
6. Pharmacokinetics is best defined as the study of:
A. The study of drug effects on the body
B. The study of drug movement throughout the body
C. The study of drug toxicity
D. The study of drug interactions
Rationale: B. Pharmacokinetics encompasses the four basic processes of
absorption, distribution, metabolism, and excretion (ADME).
7. A drug with a half-life of 6 hours will reach steady state in approximately:
A. 6 hours
B. 12 hours
C. 24–30 hours
2|Page
,Page 3 of 47
D. 48 hours
Rationale: C. Steady state is reached after approximately 4–5 half-lives.
8. What is the primary purpose of administering a loading dose of a medication?
A. To maintain steady-state levels
B. To rapidly achieve therapeutic drug concentrations
C. To reduce the risk of adverse effects
D. To prolong the drug's half-life
Rationale: B. A loading dose is given to rapidly achieve therapeutic plasma
concentrations.
9. A patient with hepatic impairment is prescribed a drug that undergoes
extensive first-pass metabolism. What is the most likely effect?
A. Decreased bioavailability
B. Increased bioavailability
C. No change in bioavailability
D. Variable bioavailability
Rationale: B. Hepatic impairment reduces first-pass metabolism, leading to
increased bioavailability.
10. What is the definition of a prodrug?
A. A drug that is active immediately upon administration
B. A drug that requires metabolic activation to become active
C. A drug that is excreted unchanged in the urine
D. A drug that has no therapeutic effect
Rationale: B. A prodrug is an inactive compound that requires metabolic
activation in the body.
11. Which of the following is a Phase II metabolic reaction?
A. Oxidation
B. Reduction
C. Hydrolysis
D. Glucuronidation
Rationale: D. Phase II reactions involve conjugation, such as glucuronidation.
3|Page
, Page 4 of 47
12. A drug follows zero-order kinetics. What does this mean?
A. A constant fraction of the drug is eliminated per unit time
B. A constant amount of drug is eliminated per unit time
C. The drug is eliminated more rapidly at higher concentrations
D. The drug is eliminated exponentially
Rationale: B. Zero-order kinetics means a constant amount of drug is eliminated
per unit time.
13. What is the primary factor that determines the onset of action of a drug?
A. Route of administration
B. Protein binding
C. Volume of distribution
D. Therapeutic index
Rationale: A. The route of administration significantly affects the onset of action.
14. A patient is taking a medication that is a potent enzyme inhibitor. What
effect will this have on other medications metabolized by the same enzyme?
A. Decreased serum levels of the other medications
B. Increased serum levels of the other medications
C. No effect on other medications
D. Decreased toxicity of other medications
Rationale: B. Enzyme inhibitors decrease the metabolism of other drugs, leading
to increased serum levels.
15. What is the definition of tachyphylaxis?
A. An increased response to a drug after repeated administration
B. A decreased response to a drug after repeated administration
C. An allergic reaction to a drug
D. An idiosyncratic reaction to a drug
Rationale: B. Tachyphylaxis is a rapid decrease in response to a drug after
repeated administration.
16. Which of the following is a primary factor that determines the distribution of
a drug?
A. Blood flow to tissues and protein binding
4|Page
